Central Laboratory, Jinan Central Hospital Affiliated to Shandong University, Jinan, 250013, People's Republic of China.
Department of Pathology, Jinan Central Hospital Affiliated to Shandong University, Jinan, 250013, People's Republic of China.
Cancer Gene Ther. 2020 Jun;27(6):473-485. doi: 10.1038/s41417-019-0125-7. Epub 2019 Jul 16.
DNA methylation has an important role in Helicobacter pylori (H. pylori)-induced gastric cancer (GC) processes and development. The aim of this study was to search genome-scale epigenetic modifications for studying pathogenesis of H. pylori-induced GC, and to find factors and powerful signature related to survival and prognosis. In this study, we conducted a comprehensive analysis of DNA methylation and gene expression profiles in the Gene Expression Omnibus (GEO), to identified differentially expressed genes (DEGs) and differentially methylated genes (DMGs). Functional enrichment analysis of the screened genes was performed, and a protein-protein interaction network was constructed. The TCGA DNA methylation databases and 55 H. pylori-infected GC cases of GEO RNA sequencing (GSE62254) were utilized for prognostic value validation of hub genes. Finally, a prognosis-related risk signature was identified by a series of bioinformatics analysis for H. pylori-induced GC patients. Totally, 161 DMGs were identified. Pathway analysis showed that all MDEGs mainly associated with Ras signaling pathway, renal cell carcinoma, mitogen-activated protein kinase signaling pathway. Five hub genes including CACNB2, GNB4, GRIN2A, MEF2C, and PREX1 were screened as independent prognostic factors in H. pylori-induced GC patients. Two-gene (CACNB2 and MEF2C) risk signature was constructed for predicting the overall survival of H. pylori-induced GC patients. Our study indicated possible MDEGs and pathways in H. pylori-induced GC by bioinformatics analysis, which may provide novel insights for unraveling pathogenesis of H. pylori-induced GC. Hub genes might serve as aberrantly methylation-based biomarkers for clinical diagnostic and prognostic evaluation of H. pylori-induced GC.
DNA 甲基化在幽门螺杆菌（H. pylori）诱导的胃癌（GC）发生和发展过程中具有重要作用。本研究旨在通过全基因组表观遗传修饰来研究 H. pylori 诱导的 GC 的发病机制，并寻找与生存和预后相关的因素和有力的特征。在这项研究中，我们对基因表达组学（GEO）中的 DNA 甲基化和基因表达谱进行了全面分析，以鉴定差异表达基因（DEGs）和差异甲基化基因（DMGs）。对筛选出的基因进行功能富集分析，并构建蛋白质-蛋白质相互作用网络。利用 TCGA DNA 甲基化数据库和 GEO RNA 测序（GSE62254）中 55 例 H. pylori 感染 GC 病例进行了关键基因预后价值验证。最后，通过一系列生物信息学分析，为 H. pylori 诱导的 GC 患者确定了一个与预后相关的风险特征。共鉴定出 161 个 DMGs。通路分析表明，所有 MDEGs 主要与 Ras 信号通路、肾细胞癌、丝裂原激活蛋白激酶信号通路相关。CACNB2、GNB4、GRIN2A、MEF2C 和 PREX1 这 5 个关键基因被筛选为 H. pylori 诱导的 GC 患者的独立预后因素。构建了由两个基因（CACNB2 和 MEF2C）组成的风险特征，用于预测 H. pylori 诱导的 GC 患者的总生存期。本研究通过生物信息学分析，提示了 H. pylori 诱导的 GC 中可能存在的差异甲基化基因和通路，这可能为阐明 H. pylori 诱导的 GC 的发病机制提供新的思路。关键基因可能作为基于异常甲基化的生物标志物，用于 H. pylori 诱导的 GC 的临床诊断和预后评估。
